Filter
839
Text search:
vaccine
trial
Featured
Recommendations
95
New Publications
169
Language
Document type
No document type
351
Studies & Reports
175
Guidelines
159
Manuals
44
Fact sheets
42
Strategic & Response Plan
25
Training Material
15
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
40
India
28
Sierra Leone
18
Kenya
18
South Africa
17
Liberia
13
Uganda
13
West and Central Africa
13
Western and Central Europe
13
Brazil
12
East and Southern Africa
11
Africa
11
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Zambia
8
Latin America and the Carribbean
8
Congo, Democratic Republic of
7
Philippines
7
South Sudan
7
Tanzania
7
Guinea
6
Zimbabwe
6
Rwanda
6
Nepal
5
Bangladesh
5
Mozambique
5
Middle East and North Africa
5
Germany
4
Malawi
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
USA
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
France
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
210
Clinical Guidelines
108
Women & Child Health
56
Public Health
35
Key Resources
18
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
74
HIV
71
Ebola & Marburg
51
NTDs
51
AMR
20
Malaria
20
Rapid Response
16
Pharmacy
15
Mental Health
14
Planetary Health
11
Global Health Education
10
Health Financing Toolbox
10
NCDs
10
Cholera
9
Refugee
8
Polio
7
Zika
7
Caregiver
6
2.0 Rapid Response
6
Conflict
5
Disability
2
Natural Hazards
1
Health Policy Plan (2017) 32 (5): 603-612; 10 pp. 318 kB
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha
...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the
...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
Doc. No.: INS/GDL/001-(Annexes)
11-17 April 2012
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
Psychiatry and Pediatrics
Chapter I.4
The report discusses the epidemiological and social aspects of ageing, health and functional changes experienced with ageing, the impact of physical activity, assessment of the nutritional status of older persons, and nutritional guidelines for healthy ageing.
This guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experienc
...
